These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30059514)

  • 1. Multimerization results in formation of re-bindable metabolites: A proof of concept study with FSC-based minigastrin imaging probes targeting CCK2R expression.
    Summer D; Kroess A; Woerndle R; Rangger C; Klingler M; Haas H; Kremser L; Lindner HH; von Guggenberg E; Decristoforo C
    PLoS One; 2018; 13(7):e0201224. PubMed ID: 30059514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting the Concept of Multivalency with
    Summer D; Rangger C; Klingler M; Laverman P; Franssen GM; Lechner BE; Orasch T; Haas H; von Guggenberg E; Decristoforo C
    Contrast Media Mol Imaging; 2018; 2018():3171794. PubMed ID: 29849512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing Targeted Hybrid Imaging Probes by Chelator Scaffolding.
    Summer D; Grossrubatscher L; Petrik M; Michalcikova T; Novy Z; Rangger C; Klingler M; Haas H; Kaeopookum P; von Guggenberg E; Haubner R; Decristoforo C
    Bioconjug Chem; 2017 Jun; 28(6):1722-1733. PubMed ID: 28462989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting.
    Klingler M; Decristoforo C; Rangger C; Summer D; Foster J; Sosabowski JK; von Guggenberg E
    Theranostics; 2018; 8(11):2896-2908. PubMed ID: 29896292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors.
    Zhai C; Franssen GM; Petrik M; Laverman P; Summer D; Rangger C; Haubner R; Haas H; Decristoforo C
    Mol Imaging Biol; 2016 Oct; 18(5):758-67. PubMed ID: 26905697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation.
    Knetsch PA; Zhai C; Rangger C; Blatzer M; Haas H; Kaeopookum P; Haubner R; Decristoforo C
    Nucl Med Biol; 2015 Feb; 42(2):115-22. PubMed ID: 25459110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic versus Noncyclic Chelating Scaffold for
    Summer D; Garousi J; Oroujeni M; Mitran B; Andersson KG; Vorobyeva A; Löfblom J; Orlova A; Tolmachev V; Decristoforo C
    Mol Pharm; 2018 Jan; 15(1):175-185. PubMed ID: 29160082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use.
    Klingler M; Summer D; Rangger C; Haubner R; Foster J; Sosabowski J; Decristoforo C; Virgolini I; von Guggenberg E
    J Nucl Med; 2019 Jul; 60(7):1010-1016. PubMed ID: 30530828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.
    Roosenburg S; Laverman P; Joosten L; Cooper MS; Kolenc-Peitl PK; Foster JM; Hudson C; Leyton J; Burnet J; Oyen WJ; Blower PJ; Mather SJ; Boerman OC; Sosabowski JK
    Mol Pharm; 2014 Nov; 11(11):3930-7. PubMed ID: 24992368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.
    Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC
    Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid Imaging Agents for Pretargeting Applications Based on Fusarinine C-Proof of Concept.
    Summer D; Petrik M; Mayr S; Hermann M; Kaeopookum P; Pfister J; Klingler M; Rangger C; Haas H; Decristoforo C
    Molecules; 2020 May; 25(9):. PubMed ID: 32370017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusarinine C, a novel siderophore-based bifunctional chelator for radiolabeling with Gallium-68.
    Zhai C; Summer D; Rangger C; Haas H; Haubner R; Decristoforo C
    J Labelled Comp Radiopharm; 2015 May; 58(5):209-14. PubMed ID: 25874571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal Infection.
    Kaeopookum P; Summer D; Pfister J; Orasch T; Lechner BE; Petrik M; Novy Z; Matuszczak B; Rangger C; Haas H; Decristoforo C
    Mol Imaging Biol; 2019 Dec; 21(6):1097-1106. PubMed ID: 30838551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial In Vitro and In Vivo Evaluation of a Novel CCK2R Targeting Peptide Analog Labeled with Lutetium-177.
    Hörmann AA; Klingler M; Rezaeianpour M; Hörmann N; Gust R; Shahhosseini S; Guggenberg EV
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33049999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89.
    Zhai C; He S; Ye Y; Rangger C; Kaeopookum P; Summer D; Haas H; Kremser L; Lindner H; Foster J; Sosabowski J; Decristoforo C
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30845658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.
    Laverman P; Roosenburg S; Gotthardt M; Park J; Oyen WJ; de Jong M; Hellmich MR; Rutjes FP; van Delft FL; Boerman OC
    Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):386-92. PubMed ID: 17934729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog
    Sauter AW; Mansi R; Hassiepen U; Muller L; Panigada T; Wiehr S; Wild AM; Geistlich S; Béhé M; Rottenburger C; Wild D; Fani M
    J Nucl Med; 2019 Mar; 60(3):393-399. PubMed ID: 30002107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrin and cholecystokinin peptide-based radiopharmaceuticals: an in vivo and in vitro comparison.
    Tornesello AL; Aurilio M; Accardo A; Tarallo L; Barbieri A; Arra C; Tesauro D; Morelli G; Aloj L
    J Pept Sci; 2011 May; 17(5):405-12. PubMed ID: 21351319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours.
    Good S; Walter MA; Waser B; Wang X; Müller-Brand J; Béhé MP; Reubi JC; Maecke HR
    Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1868-77. PubMed ID: 18509636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates.
    Zhai C; Summer D; Rangger C; Franssen GM; Laverman P; Haas H; Petrik M; Haubner R; Decristoforo C
    Mol Pharm; 2015 Jun; 12(6):2142-50. PubMed ID: 25941834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.